Skip to main content
. 2017 Aug 3;7:7211. doi: 10.1038/s41598-017-07830-4

Figure 3.

Figure 3

SLC39A4 silencing inhibits A549 cells metastasis in vitro. (a,b) SLC39A4 expression in A549 knockdown and empty vector control (Ctl) cells by western blot analysis (a) and qPCR (b,c). Zn2+ concentration in A549 cells after knockdown of SLC39A4 in vivo. (d,e) Analysis of SLC39A4 knockdown and Ctl cell migration in wound-healing assays (scale bar, 500 μm). Representative images (d) and quantitation (e) are shown. (f,g) Cell migration was monitored in transwell assays with SLC39A4 knockdown and Ctl A549 cells (scale bar, 100 μm). Representative images (f) and quantitation (g) are shown. (h,i) Cell invasion was monitored in matrigel transwell assays with SLC39A4 knockdown and Ctl A549 cells (scale bar, 100 μm). Representative images (h) and quantitation (i) are shown. (j,k) Analysis of E-cadherin (epithelial marker) and FSP-1 and N-cadherin (mesenchymal markers) expression in knockdown and control cells by immunofluorescence staining (j) and western blotting (k) (scale bar, 50 μm).